Rick E. Winningham, Director at Jazz Pharmaceuticals plc (JAZZ), sold 801 shares at $179.98 ($144K) on 2015-08-10, disclosed to the SEC on 2015-08-11.
Seasonal sale ($144k) by Director — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $179.98 | 797 | $143K | 99.5% |
| 2 | $183.36 | 4 | $733 | 0.5% |
| Total | $180.00 avg | 801 | $144K | 100% |
| Filing → |
| JAZZ | SELL | 2023-08-15 | $343K | — | Filing → |
| TBPH | SELL | 2022-12-16 | $560K | — | Filing → |
| JAZZ | SELL | 2022-08-09 | $332K | — | Filing → |